Gilead Remdesivir Drug Is Cleared for Emergency Use by FDA, Trump Says
Remdesivir is a Gilead science antiviral medicine, patients in Chicago hospitals who are treated with the experimental drug have been recovering quickly, with most going home in days.
The Food and Drug Administration FDA on Friday granted use of an experimental drug that appears to help some coronavirus patients recover faster.
It was authorized for emergency use to treat the most severely ill COVID-19 patients. It is the first drug shown to help fight COVID-19, which has killed more than 230,000 people worldwide.
The study of 1,063 patients is the largest and most strict test of the drug and included a comparison group that received just usual care so remdesivir’s effects could be rigorously evaluated. Those given the drug were able to leave the hospital in 11 days on average versus 15 days for the comparison group.
FDA Commissioner Stephen Hahn, speaking with Trump, said the drug was being cleared for emergency use in hospitalized patients